FARAPULSE PFA

Technology

Last mentioned: Mar 23, 2026

Timeline

  1. Litigation Notice

    Pomerantz LLP issues first public alert regarding the class action filing against Boston Scientific.

  2. Form 8-K Filing

    BSX files notice with the SEC regarding 'Other Events' involving executive shifts and operational updates.

  3. Q4 2025 Earnings

    Company reports financial results and provides updated guidance on clinical timelines.

  4. AVANT GUARD Trial Pause

    Boston Scientific announces a pause in its FARAPULSE PFA trial, citing the need for data review.

Stories mentioning FARAPULSE PFA 1

medical-devices Neutral

Boston Scientific Faces Class Action Scrutiny Over Alleged Disclosure Failures

Pomerantz LLP has initiated a class action investigation and filing against Boston Scientific Corporation (BSX), alleging the medical device giant made misleading statements regarding its clinical trials and business prospects. The litigation follows a period of heightened volatility for the company's cardiovascular portfolio, specifically concerning the FARAPULSE PFA system and recent trial adjustments.

2 sources